<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41007790</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Lysyl Oxidase-like 2-Guided Benefits of Early Cardiac Rehabilitation in Acute Heart Failure: A Prospective Cohort Study in Taiwan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2228</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines13092228</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> The objectives of this study were to determine whether the early initiation of cardiac rehabilitation (CR) within 6 weeks of discharge improves long-term outcomes in patients hospitalized for acute heart failure (HF) and to evaluate whether baseline lysyl oxidase-like 2 (LOXL2) levels affect the response to CR. <b>Methods:</b> We prospectively enrolled patients with acute HF who completed a structured Heart Failure Disease Management Program between January 2019 and July 2022. Participants were categorized into an early-CR group (initiating supervised CR within 6 weeks post-discharge and continuing a home-based program) or a non-CR group. The primary outcome was all-cause mortality. The secondary outcomes included HF rehospitalization and changes in scores on the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12) at 6 and 12 months. A post hoc analysis was conducted to stratify patients by baseline LOXL2 levels in order to assess differential CR effects in relation to the severity of cardiac fibrosis. <b>Results:</b> Out of 162 patients, 34 participated in early CR. After 1:1 propensity score matching, each group contained 33 patients. Over a median follow-up of 2.85 years, the early-CR group experienced lower all-cause mortality (0 vs. 87.2 events per 1000 patient-years; rate difference: -0.087). A subgroup analysis revealed the greatest benefit among patients with LOXL2 levels &gt; 200 pg/mL (0 vs. 172.3 events per 1000 patient-years; rate difference: -0.172). <b>Conclusions:</b> Early post-discharge CR was associated with improved survival in patients with acute HF. The survival benefit was more pronounced in patients with an elevated level of LOXL2, suggesting its potential role as a biomarker for fibrosis-guided CR strategies. Health systems seeking scalability may consider embedding exercise-based and biomarker-guided CR programs within clinical networks early on to improve access while advancing patient-centered care. Further randomized trials are warranted to confirm these findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shyh-Ming</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0001-5256-7429</Identifier><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin-Yi</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0001-6447-3999</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Hao-Yi</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Chin-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Nursing, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>You-Cheng</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Po-Jui</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-8391-1285</Identifier><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chien-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hang</LastName><ForeName>Chi-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leu</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yung-Lung</ForeName><Initials>YL</Initials><Identifier Source="ORCID">0000-0001-7465-0880</Identifier><AffiliationInfo><Affiliation>Section of Cardiology, Department of Internal Medicine, Heart Failure Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CMRPG8P0061</GrantID><Agency>Chang Gung Memorial Hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute heart failure</Keyword><Keyword MajorTopicYN="N">cardiac rehabilitation</Keyword><Keyword MajorTopicYN="N">lysyl oxidase-like 2</Keyword><Keyword MajorTopicYN="N">mortality</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41007790</ArticleId><ArticleId IdType="pmc">PMC12467707</ArticleId><ArticleId IdType="doi">10.3390/biomedicines13092228</ArticleId><ArticleId IdType="pii">biomedicines13092228</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shahim B., Kapelios C.J., Savarese G., Lund L.H. Global Public Health Burden of Heart Failure: An Updated Review. Card. Fail. Rev. 2023;9:e11. doi: 10.15420/cfr.2023.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/cfr.2023.05</ArticleId><ArticleId IdType="pmc">PMC10398425</ArticleId><ArticleId IdType="pubmed">37547123</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.L., Chao T.F., Tsai C.T., Liao J.N., Lim S.S., Tuan T.C., Chen T.J., Chan Y.H., Chen S.A., Chiang C.E. Prevalence, Incidence, Lifetime Risks, and Outcomes of Heart Failure in Asia: A Nationwide Report. JACC Heart Fail. 2023;11:1454&#x2013;1456. doi: 10.1016/j.jchf.2022.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2022.07.012</ArticleId><ArticleId IdType="pubmed">36647927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjarnason-Wehrens B., Nebel R., Jensen K., Hackbusch M., Grilli M., Gielen S., Schwaab B., Rauch B., Prevention German Society of Cardiovascular, and Rehabilitation Exercise-Based Cardiac Rehabilitation in Patients with Reduced Left Ventricular Ejection Fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (Cros-Hf): A Systematic Review and Meta-Analysis. Eur. J. Prev. Cardiol. 2020;27:929&#x2013;952. doi: 10.1177/2047487319854140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487319854140</ArticleId><ArticleId IdType="pmc">PMC7272131</ArticleId><ArticleId IdType="pubmed">31177833</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor C.M., Whellan D.J., Lee K.L., Keteyian S.J., Cooper L.S., Ellis S.J., Leifer E.S., Kraus W.E., Kitzman D.W., Blumenthal J.A., et al. Efficacy and Safety of Exercise Training in Patients with Chronic Heart Failure: Hf-Action Randomized Controlled Trial. JAMA. 2009;301:1439&#x2013;1450. doi: 10.1001/jama.2009.454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.454</ArticleId><ArticleId IdType="pmc">PMC2916661</ArticleId><ArticleId IdType="pubmed">19351941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-M., Wang L.-Y., Liaw M.-Y., Wu M.-K., Wu P.-J., Wei C.-L., Chen A.-N., Su T.-L., Chang J.-K., Yang T.-H., et al. Outcomes with Multidisciplinary Cardiac Rehabilitation in Post-acute Systolic Heart Failure Patients&#x2014;A Retrospective Propensity Score-Matched Study. Front. Cardiovasc. Med. 2022;9:763217. doi: 10.3389/fcvm.2022.763217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.763217</ArticleId><ArticleId IdType="pmc">PMC9039246</ArticleId><ArticleId IdType="pubmed">35498011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitzman D.W., Whellan D.J., Duncan P., Pastva A.M., Mentz R.J., Reeves G.R., Nelson M.B., Chen H., Upadhya B., Reed S.D., et al. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure. N. Engl. J. Med. 2021;385:203&#x2013;216. doi: 10.1056/NEJMoa2026141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2026141</ArticleId><ArticleId IdType="pmc">PMC8353658</ArticleId><ArticleId IdType="pubmed">33999544</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S., Gonz&#xe1;lez A., Pizard A., Papageorgiou A.P., L&#xf3;pez-Andr&#xe9;s N., Jaisser F., Thum T., Zannad F., D&#xed;ez J. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential. Eur. J. Heart Fail. 2015;17:764&#x2013;771. doi: 10.1002/ejhf.312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.312</ArticleId><ArticleId IdType="pubmed">26126780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Winkler J., Ramos I., Do Q., Firat H., McDonald K., Gonz&#xe1;lez A., Thum T., D&#xed;ez J., Jaisser F., et al. Myocardial fibrosis: Biomedical research from bench to bedside. Eur. J. Heart Fail. 2017;19:177&#x2013;191. doi: 10.1002/ejhf.696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.696</ArticleId><ArticleId IdType="pmc">PMC5299507</ArticleId><ArticleId IdType="pubmed">28157267</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer R.A., De Keulenaer G., Bauersachs J., Brutsaert D., Cleland J.G., Diez J., Du X., Ford P., Heinzel F.R., Lipson K.E., et al. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur. J. Heart Fail. 2019;21:272&#x2013;285. doi: 10.1002/ejhf.1406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1406</ArticleId><ArticleId IdType="pmc">PMC6607480</ArticleId><ArticleId IdType="pubmed">30714667</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-M., Wu M.-K., Chen C., Wang L.-Y., Guo N.-W., Wei C.-L., Zheng Y.-C., Hsiao H.-Y., Wu P.-J., Chen Y.-L., et al. Benefit of cardiac rehabilitation in acute heart failure patients with cognitive impairment. Heliyon. 2024;10:e30493. doi: 10.1016/j.heliyon.2024.e30493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2024.e30493</ArticleId><ArticleId IdType="pmc">PMC11079101</ArticleId><ArticleId IdType="pubmed">38726193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gismondi A., Iellamo F., Caminiti G., Sposato B., Gregorace E., D&#x2019;Antoni V., Di Biasio D., Vadal&#xe0; S., Franchini A., Mancuso A., et al. Rate of Perceived Exertion Based on Repetitions in Reserve Versus Percentage of One-Repetition Maximum for Resistance Training Prescription in Cardiac Rehabilitation: A Pilot Study. J. Cardiovasc. Dev. Dis. 2025;12:8. doi: 10.3390/jcdd12010008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd12010008</ArticleId><ArticleId IdType="pmc">PMC11766398</ArticleId><ArticleId IdType="pubmed">39852286</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Savvatis K., Kang J.S., Fan P., Zhong H., Schwartz K., Barry V., Mikels-Vigdal A., Karpinski S., Kornyeyev D., et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat. Commun. 2016;7:13710. doi: 10.1038/ncomms13710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13710</ArticleId><ArticleId IdType="pmc">PMC5171850</ArticleId><ArticleId IdType="pubmed">27966531</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez A.F., Greiner M.A., Fonarow G.C., Hammill B.G., Heidenreich P.A., Yancy C.W., Peterson E.D., Curtis L.H. Relationship Between Early Physician Follow-up and 30-Day Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure. JAMA. 2010;303:1716&#x2013;1722. doi: 10.1001/jama.2010.533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.533</ArticleId><ArticleId IdType="pubmed">20442387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-M., Fang Y.-N., Wang L.-Y., Wu M.-K., Wu P.-J., Yang T.-H., Chen Y.-L., Hang C.-L. Impact of multi-disciplinary treatment strategy on systolic heart failure outcome. BMC Cardiovasc. Disord. 2019;19:220. doi: 10.1186/s12872-019-1214-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-019-1214-0</ArticleId><ArticleId IdType="pmc">PMC6794772</ArticleId><ArticleId IdType="pubmed">31615409</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Zhuge W., Huang H., Zhang T., Ge X. The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: A systematic review and meta-analysis. Int. J. Nurs. Stud. 2022;130:104237. doi: 10.1016/j.ijnurstu.2022.104237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104237</ArticleId><ArticleId IdType="pubmed">35421772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H., Caforio A.L.P., Crea F., Goudevenos J.A., Halvorsen S., et al. 2017 Esc Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with St-Segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with St-Segment Elevation of the European Society of Cardiology (Esc) Eur. Heart J. 2018;39:119&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., et al. 2022 Aha/Acc/Hfsa Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e876&#x2013;e894. doi: 10.1161/CIR.0000000000001062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001062</ArticleId><ArticleId IdType="pubmed">35363500</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzan N., Matsushima S., Kaku H., Tohyama T., Nezu T., Higuchi T., Nagatomi Y., Fujino T., Hashimoto T., Ide T., et al. Propensity-Matched Study of Early Cardiac Rehabilitation in Patients With Acute Decompensated Heart Failure. Circ. Heart Fail. 2023;16:e010320. doi: 10.1161/CIRCHEARTFAILURE.122.010320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.122.010320</ArticleId><ArticleId IdType="pmc">PMC10101139</ArticleId><ArticleId IdType="pubmed">37026462</ArticleId></ArticleIdList></Reference><Reference><Citation>McKelvie R.S. Exercise training in patients with heart failure: Clinical outcomes, safety, and indications. Heart Fail. Rev. 2008;13:3&#x2013;11. doi: 10.1007/s10741-007-9052-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-007-9052-z</ArticleId><ArticleId IdType="pubmed">17960476</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy C., Long L., Mordi I.R., Bridges C., Sagar V.A., Davies E.J., Coats A.J., Dalal H., Rees K., Singh S.J., et al. Exercise-Based Cardiac Rehabilitation for Adults with Heart Failure. Cochrane Database Syst. Rev. 2024;3:CD003331. doi: 10.1002/14651858.cd003331.pub6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd003331.pub6</ArticleId><ArticleId IdType="pmc">PMC10919451</ArticleId><ArticleId IdType="pubmed">38451843</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley B., Harrison S., Fazio-Eynullayeva E., Underhill P., Sankaranarayanan R., Wright D., Thijssen D., Lip G. Cardiac rehabilitation and all-cause mortality in patients with heart failure: A retrospective cohort study. Eur. J. Prev. Cardiol. 2021;28:1704&#x2013;1710. doi: 10.1093/eurjpc/zwab035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwab035</ArticleId><ArticleId IdType="pubmed">34333607</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi T., Iritani N., Kamiya K., Iwatsu K., Kamisaka K., Iida Y., Yamada S. Prognostic Effects of Cardiac Rehabilitation in Patients With Heart Failure (from a Multicenter Prospective Cohort Study) Am. J. Cardiol. 2022;164:79&#x2013;85. doi: 10.1016/j.amjcard.2021.10.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.10.038</ArticleId><ArticleId IdType="pubmed">34848049</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni A., Vinci R., D&#x2019;aiello A., Grimaldi M.C., Di Sario M., Tarquini D., Proto L., Severino A., Pedicino D., Liuzzo G. Targeting Collagen Pathways as an HFpEF Therapeutic Strategy. J. Clin. Med. 2023;12:5862. doi: 10.3390/jcm12185862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12185862</ArticleId><ArticleId IdType="pmc">PMC10531642</ArticleId><ArticleId IdType="pubmed">37762803</ArticleId></ArticleIdList></Reference><Reference><Citation>Homsi R., Luetkens J.A., Skowasch D., Pizarro C., Sprinkart A.M., Gieseke J., Meyer-Arend J.M.Z.H.G., Schild H.H., Naehle C.P. Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients with Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study. J. Thorac. Imaging. 2017;32:36&#x2013;42. doi: 10.1097/RTI.0000000000000248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000248</ArticleId><ArticleId IdType="pubmed">27861208</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez C., Mart&#xed;nez-Gonz&#xe1;lez J. The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling. Cells. 2019;8:1483. doi: 10.3390/cells8121483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121483</ArticleId><ArticleId IdType="pmc">PMC6953057</ArticleId><ArticleId IdType="pubmed">31766500</ArticleId></ArticleIdList></Reference><Reference><Citation>Poe A., Yus M.M., Wang H., Santhanam L. Lysyl oxidase like-2 in fibrosis and cardiovascular disease. Am. J. Physiol. Physiol. 2023;325:C694&#x2013;C707. doi: 10.1152/ajpcell.00176.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00176.2023</ArticleId><ArticleId IdType="pmc">PMC10635644</ArticleId><ArticleId IdType="pubmed">37458436</ArticleId></ArticleIdList></Reference><Reference><Citation>van Tol B.A., Huijsmans R.J., Kroon D.W., Schothorst M., Kwakkel G. Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis. Eur. J. Heart Fail. 2006;8:841&#x2013;850. doi: 10.1016/j.ejheart.2006.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejheart.2006.02.013</ArticleId><ArticleId IdType="pubmed">16713337</ArticleId></ArticleIdList></Reference><Reference><Citation>Green D.J., Hopman M.T.E., Padilla J., Laughlin M.H., Thijssen D.H.J. Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli. Physiol. Rev. 2017;97:495&#x2013;528. doi: 10.1152/physrev.00014.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00014.2016</ArticleId><ArticleId IdType="pmc">PMC5539408</ArticleId><ArticleId IdType="pubmed">28151424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Deng Y., Xiao H. Exercise and cardiac fibrosis. Curr. Opin. Physiol. 2023;31:100630. doi: 10.1016/j.cophys.2022.100630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cophys.2022.100630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Wang J., Liu H., Chen Y., Ma X., Chen S., Chen Y., Bihl J., Yang Y. Moderate Exercise Enhances Endothelial Progenitor Cell Exosomes Release and Function. Med. Sci. Sports Exerc. 2018;50:2024&#x2013;2032. doi: 10.1249/MSS.0000000000001672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000001672</ArticleId><ArticleId IdType="pubmed">30222687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke X., Yang D., Liang J., Wang X., Wu S., Wang X., Hu C. Human Endothelial Progenitor Cell-Derived Exosomes Increase Proliferation and Angiogenesis in Cardiac Fibroblasts by Promoting the Mesenchymal&#x2013;Endothelial Transition and Reducing High Mobility Group Box 1 Protein B1 Expression. DNA Cell Biol. 2017;36:1018&#x2013;1028. doi: 10.1089/dna.2017.3836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2017.3836</ArticleId><ArticleId IdType="pubmed">28920705</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;aLleva A., Leigheb F., Rinaldi C., Di Stanislao F., Vanhaecht K., De Ridder D., Bruyneel L., Cangelosi G., Panella M. Achieving quadruple aim goals through clinical networks: A systematic review. J. Healthc. Qual. Res. 2019;34:29&#x2013;39. doi: 10.1016/j.jhqr.2018.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhqr.2018.10.010</ArticleId><ArticleId IdType="pubmed">30713135</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh A., Bodaghkhani E., Etchegary H., Alcock L., Patey C., Senior D., Asghari S. Patient-centered care in the emergency department: A systematic review and meta-ethnographic synthesis. Int. J. Emerg. Med. 2022;15:36. doi: 10.1186/s12245-022-00438-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12245-022-00438-0</ArticleId><ArticleId IdType="pmc">PMC9367087</ArticleId><ArticleId IdType="pubmed">35953783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghisi G.L.M., Bomtempo A.P.D., Gonzalez N.F., Reyes G.P., Anchique C.V. Evaluating the Clinical Effectiveness of Cardiac Rehabilitation among Patients of Very Low Socioeconomic Status Living in Colombia. J. Cardiovasc. Dev. Dis. 2024;11:255. doi: 10.3390/jcdd11090255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd11090255</ArticleId><ArticleId IdType="pmc">PMC11432289</ArticleId><ArticleId IdType="pubmed">39330313</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou V., Davos C.H., Kapreli E., Batalik L., Panagiotakos D.B., Pepera G. Effectiveness of Home-Based Cardiac Rehabilitation, Using Wearable Sensors, as a Multicomponent, Cutting-Edge Intervention: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:3772. doi: 10.3390/jcm11133772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133772</ArticleId><ArticleId IdType="pmc">PMC9267864</ArticleId><ArticleId IdType="pubmed">35807055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>